Malignant neoplasm of kidney, except renal pelvis Clinical Trials
60 clinical trials for Malignant neoplasm of kidney, except renal pelvis across international registries, including 20 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Search for exosomal biomarkers for urological tumors — RECRUITING
- UMBRELLA Protocol SIOP-RTSG 2016 - Integrated research and guidelines for standardized diagnostics and therapy of kidney tumours in children, adolescents and young adults — RECRUITING
- Non-interventional, prospective study to evaluate the predictive potential of early CRP kinetics, in particular the CRP flare-response phenomenon, on the efficacy of immunotherapy in advanced urooncological tumors (renal cell carcinoma, urothelial carcinoma).
"Prospective Evaluation of the CRP-FLAre phenomenon on Immunotherapy REsponse in Urooncology (FLAIRE)." — RECRUITING
- Kidney Tumor Study München Klinik Bogenhausen — RECRUITING
- Randomized multi-centre open-label non-inferiority phase 3 clinical trial for patients with a stage IV childhood renal tumour comparing upfront Vincristine, Actinomycin-D and Doxorubicin (VAD, standard arm) with upfront Vincristine, Carboplatin and Etoposide (VCE, experimental arm) — RECRUITING
- Prospective observational study to investigate the long-term course of MR-guided percutaneous tumor ablation of primary or secondary liver or kidney tumors — RECRUITING
- Kidney Tumor Study Klinikum Region Hannover — RECRUITING
- An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma — RECRUITING · PHASE2
- Ex vivo Identification of Specific Gene Vector Capsids for Tumor-targeted Gene Therapy with Adeno-associated Viral Vectors — RECRUITING
- Clinical implementation and real-world outcomes of single-port robot-assisted laparoscopic procedures at a university medical centre — RECRUITING
- GUARDIANS-Registry
(GenitoUrinary Academic Research Development Initiative and Network) — RECRUITING
- Improvement of the quality of care through standardized documentation — RECRUITING
- Mainz Kidney cancer observational Registry study — RECRUITING
- Molecular biological and cellular characterization of urological tumours
tumors for the investigation of tumorigenesis, metastasis and therapy response
response to therapy, as well as establishment of an organoid and biobank
of urological tumors — RECRUITING
- Retro and prospective Evaluation of the results of biopsies and ablations of renal massens at the University Medical Center Goettingen — RECRUITING
- Ultrasound guided Continuous Transmuscular Quadratus Lumborum Block (QLB 3) for post operative analgesia, in patients undergoing radical nephrectomy. A randomized controlled trial — RECRUITING
- Value of FGFR alterations on treatment outcomes in bladder cancer: a multicenter collaboration project — RECRUITING
- Biomarker associated with the radiation therapy of renal cell cancer. — RECRUITING
- Prospective evaluation of a preoperative geriatic assessment as predictor of clinical outcome after major urological tumor surgery. — RECRUITING
- Molecular determinants for therpy response on renal cell carcinoma. — RECRUITING
- Assessing response to treatment using imaging with PET/MRI in advanced renal cancer — ACTIVE_NOT_RECRUITING
- Stereotactic radiotherapy versus HDR brachytherapy (Ir-192, reloading procedure) for T1 (≤7 cm) inoperable, non-metastatic renal tumours 2017-2023 — OTHER
- Regular vs early unclamping in robotic partial nephrectomy (REVUPAN): A randomized controlled trial — OTHER
- Functional and oncologic outcomes after open, laparoscopic and robotic partial kidney resection: in-depth medium-term follow-up of a population-based sample from the Hessian Cancer Registry (APPROACH study) — OTHER
- Non-interventional study on Therapeutic Drug Monitoring (TDM) in patients with renal cell carcinoma and on the feasibility of using Volumetric Absorptive Microsampling (VAMS) for sample collection (ON-TARGET) — OTHER
- AKOM - Improvement of the well-being and quality of life of kidney tumor patients after standardized information on the importance of complementary medicine approaches — NOT_YET_RECRUITING
- VONKO-033: Characteristics, treatment patterns and survival among adults with renal carcinoma, with a particular focus on subgroups of patients with (a) renal cell carcinoma and (b) early-stage renal cell carcinoma receiving adjuvant therapy – a study based on cancer registry data — NOT_YET_RECRUITING
- Phase I study of a gene modified, B7/IL-7-transfected allogeneic tumor cell vaccine for the treatment of metastatic renal cell carcinoma — OTHER
- TDM of Axitinib, Cabozantinib and Lenvatinib in patients with renal cell carcinoma — NOT_YET_RECRUITING
- Optimization of polypharmacy in geriatric oncology — OTHER
- Study on the requirement of drain placement during open partial nephrectomy — OTHER
- Retroperitoneal versus transperitoneal robotic partial nephrectomy. A randomized controlled study. — OTHER
- Use and acceptance of a psycho-oncological online help for urogenital cancers — OTHER
- Multispectral/Hyperspectral Imaging for Surgery — OTHER
- Characterisation of kinetics of biomarkers for cell ageing and resilience in geriatric tumorpatients after urooncological operations. — OTHER
- Can interdisciplinary tumor boards for determining the further procedure in patients with urological carcinoma be equivalently replaced by appropriately trained Large Language Models (LLMs)? Results of a multicenter study on the concordance and differences in the recommendations of real tumor boards and virtual LLM tumor boards. — NOT_YET_RECRUITING
- Outcome of transperitoneal versus retroperitoneal robot assisted partial nephrectomy — OTHER
- Advanced non-invasive monitoring for individual and patient-adapted anesthesia management — NOT_YET_RECRUITING
- Tivozanib - Real World Experience on Tolerability, Patient Reported Outcomes and QoL in 1st line aRCC — OTHER
- Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapy: efficacy and outcome — OTHER
- Pre-surgery assessment for patient-related outcome after an extensive urological tumorsurgery, validation of the Erlangen-Index — OTHER
- Prospective, monocentric, clinical phase-I/II study of the effectivness of the percutaneous irrversible electropration (IRE) of locally confined kidney tumors (renal cell carcinomas) - IRENE. — OTHER
- Imaging and urine biomarkers for renal tumor assessment. — NOT_YET_RECRUITING
- Propagation of organoids from urology tumors — NOT_YET_RECRUITING
- Impact of remote ischemic preconditioning (RIPC) on kidney function and microRNA-signature of extracellular vesicles following partial nephrectomy: a randomized, prospective trial — NOT_YET_RECRUITING
- Surgical treatment for oligoprogression in metastasized renal cell carcinoma after medical treatment — NOT_YET_RECRUITING
- MR-guided, percutaneous microwave ablation of primary and secondary malignant tumors of liver and kidney — OTHER
- Advance Care Planning - wishes and views of patients with incurable cancer towards consultations for end-of-life treatment decisions — NOT_YET_RECRUITING
- Pharmacogenetic sub-study within the research project „Structure Optimization for Children with Cancer after Therapy with Anthracyclines (LESS-Anthra)“ — OTHER
- Pulse wave velocity and intima-media thickness as an indication of cardiovascular degeneration in patients after chemotherapy in childhood and adolescence. — OTHER
Refine this search